American Spraytech is a Turnkey Innovator, Formulator, and Filler of Personal Care and OTC Aerosol and Bag-On-Valve Spray Products.
Ambeed Inc.
Ambeed is a trusted research supplier supporting oncology discovery from early chemistry through translational biology worldwide. We provide high-quality building blocks, advanced intermediates, inhibitors, peptides, bio-conjugation reagents, recombinant proteins, antibodies, and custom synthesis support for academic labs, biotech companies, CROs, and pharmaceutical teams. Our portfolio is well aligned with AACR 2026’s emphasis on precision, partnership, and purpose across cancer biology, translational research, therapeutics, biomarkers, and clinical innovation. Backed by a broad in-stock inventory, Ambeed offers more than 11,000 inhibitors and agonists, 13,000 fluorinated building blocks, 7,000 amino acids and peptides, 7,000 boronic acids and esters, and 5,000 XDCs and PROTAC-related products, alongside additional core categories for hit-to-lead and oncology research. Our materials are supported by responsive service, flexible sourcing, and quality-focused manufacturing capabilities, including scale-up support up to 100 kg, a 300,000 sq. ft. facility, and a team of over 200 scientists. Stop by our booth and let’s explore how we can strengthen your ongoing pipelines.
ALSTEM, Inc.
ALSTEM, headquartered in the San Francisco Bay Area, is at the forefront of advancing stem cell research and cell engineering, offering essential tools and services to support wide-ranging life science research. Our commitment is reflected in innovative solutions for drug discovery, cell therapy, regenerative medicine, toxicity testing, cancer research, and more. Our products include Cell Line Immortalization Kits, iPSC Generation Kits, Reporter Cell Lines, Gene Editing tools, iPS Cell Lines, Lentiviral Expression and Reporter Vectors, and Virus Packaging Tools. At ALSTEM, we understand the evolving needs of scientists and continuously strive to provide cutting-edge solutions that fuel progress in these dynamic fields. Drawing from our expertise in iPS reprogramming, gene editing, and stable cell line generation, we deliver a comprehensive suite of specialized services. These encompass iPSC Generation and Reprogramming, Stable Cell Line Generation and Immortalization, Lentiviral Vector Construction and Virus Packaging, and Genome Editing leveraging CRISPR/Cas9 Knockin, Knockout, Gene Tagging, Gene Deletion, Point Mutation, and Conditional Knockout techniques. At ALSTEM, we are committed to delivering tailored solutions to meet the unique demands of cutting-edge research and development in the fields of stem cell biology and cell engineering.
ALS Group USA, Corp
ALS is a and FDA registered ISO 9001:2008 certified full service GMP contract laboratory specializing in Clinical safety and efficacy, Analytical Chemistry, Microbiology, Stability, and toxicology services. ALS is also the main provider of QVC dossier review and compliance testing.
AlpalifeBio
AlpalifeBio is a contract research organization focused on VHH discovery and functional verification services. We have established VHH discovery platform, antibody engineering platform, quality analysis platform and protein purification platform with multiple expression systems, including bacteria, yeast, insect and mammalian cell expression systems, providing one-stop solution for VHH custom discovery. | AlpalifeBio provides customized services for nanobody drugs R&D at various stages, such as nanobody/VHH discovery, humanization, affinity maturation and cell-based functional evaluation. We also provide services of expression, purification, and functional evaluation of GPCRs, an important family of drug target proteins. | AlpalifeBio is a contract research organization focused on VHH discovery and functional verification services. We have established VHH discovery platform, antibody engineering platform, quality analysis platform and protein purification platform with multiple expression systems, including bacteria, yeast, insect and mammalian cell expression systems, providing one-stop solution for VHH custom research. Also, we have anti-tag VHH products (such as VHHs against FLAG, HA, MYC, GFP, mCherry, mIgG) and proteases (such as 3C, TEV, SUMO). | AlpalifeBio thrilled to announce that Professor George F. Gao, a globally recognized scientist and leader in immunology, virology, and biotechnology, has joined AlpalifeBio as our Technical Support Chief Scientist. His extensive experience and groundbreaking research will further strengthen our commitment to advancing single-domain antibody (VHH) research and therapeutic applications.
Almac Group
Almac Diagnostic Services We are a precision medicine company specialising in biomarker driven clinical trials. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions. Our cores services: * Multi-Omic Services: We offer a range of genomic & proteomic platform and chemistry options, alongside expert data sciences support & a specialty central lab service. * Clinical Biomarker & CDx Development: Custom Clinical Biomarker & CDx development, validation & delivery service from our CLIA & CAP accredited laboratories in USA, Europe and APAC. * Clinical Testing: Global clinical trial testing service from our clinical laboratories, including a menu of platforms & assays and an integrated specimen collection & logistics service. Find Out More www.almacgroup.com/diagnostics | The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Almac possesses a wealth of technical expertise to support the delivery of your complex projects. Our scientists can develop your clinical candidate into an optimum formulation, and solid manufacture oral dose products for all stages of clinical trials. Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. We specialise in the manufacture & primary packaging of solid, oral dosage forms (Tablets, Capsules and Powders). As well as customised secondary packaging for all drug products including ultra-low temperature drug products. Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options. | Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Providing end-to-end integrated solutions to bring your drug product from development through to commercialisation from a single source. We work with clients to provide pharmaceutical development, manufacturing, product launch, and packaging solutions to fit their unique needs. Our team of experts can support the development of fit-for-purpose formulation for First-in-Human trials, to developing a more robust formulations scaling up for late phase trials, and ultimately commercialisation. Supporting key development and manufacture areas such as paediatrics, potent and highly potent products. We provide primary and secondary packaging for all drug products including ultra-low temperature drug products and specialised kit assembly. Almac was one of the 1st EU CDMOs to support gene therapy product launches, and currently supports 25% of EU approved/pre-registration Gene Therapy solutions. We provide end-to-end management of drug product supply, including distribution, packaging design, and support initial and ongoing global product launch. We provide unique, tailormade solutions designed to support the efficient and successful development, and commercialisation of new treatment options. Partnering with our clients to provide flexible, stable, ongoing supply to meet their product pipeline needs. | The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. A privately owned organisation, under the McClay Foundation, Almac has grown organically over the past five decades, now employing over 7,500 highly skilled individuals across 18 locations in Europe, the US and Asia. Almac Group is comprised of 5 Business Units: • Almac Diagnostic Services • Almac Sciences • Almac Pharma Services • Almac Clinical Services • Almac Clinical Technologies Each Business Unit offers specialist and dedicated solutions at each phase of the product lifecycle providing the ability to select single or multiple, integrated solutions to meet your unique needs. Our unique combination of inspirational people, exceptional innovation and outstanding quality, enables us to provide tailored solutions for your specific requirements – either on a single, standalone project or on a long-term basis as your strategic partner. About Almac Pharma Services: With over 55 years’ experience, Almac Pharma Services is an established, reliable and world leading outsourcing partner to the global pharmaceutical and biotechnology industry. Employing over 1,800 highly skilled individuals across 4 locations in Europe and the US, we provide a range of tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios across more than 70 countries, our fully integrated, end-to-end solutions are tailored to meet the needs of your unique products, and, ultimately, your patients. Pharmaceutical Development Solutions: Spanning both early and late phase development, our teams of expert scientists possess a wealth of experience in developing clinical candidates into optimal formulations and manufacturing high-quality oral dose products for all phases of clinical trials. Operating both non-GMP and GMP facilities we have complementary equipment trains and integrated technical teams to facilitate technology transfer providing a seamless transition between formulation and process development, and clinical trial material manufacturing. Through a range of flexible and fully tailored unit operations including blending, roller compaction, high shear granulation, encapsulation (including Xcelodose) micro encapsulation and fluid bed processing, we offer the following oral dose formulations with batch sizes ranging from grams to tons: • API / powder in hard gelatin capsules or bottles, including micro-dosing • Formulated blends in hard gelatin capsules or bottles • Tablets (coated) • Mini-tablets • Granules • Beads/pellets • Non-sterile liquid in capsules or bottles • Immediate and modified release • Fixed dose combination products • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug development expertise Analytical Solutions: We employ over 700 highly skilled analysts working in state-of-the-art, fully certified GMP laboratories across Europe and the US with significant experience in the analysis of both small and large molecules. We support drug substance (API) and drug product (finished product) analytics across all phases of clinical development through to commercial release. We offer a range of tailored services including: • Method development • Method validation • Method transfer • Stability programmes • Release analysis: all lifecycle stages • Spectroscopy services • Investigational analysis • Reference standard management • Microbiological testing • Physical sciences • Bio-pharmaceutical testing • Analytical support for clinical trial supplies Commercial Manufacture Solutions: Scaling up from our oral dose development assets and expertise through registration and launch into commercial supply, or transferring existing commercial products, we support your commercial manufacturing needs with flexibility and expertise. With blend sizes from 10kgs up to 2.5 tons, our range of state-of-the-art processing equipment is designed to enable scalability to the batch size requirements of your product for a range of presentations including: • Tablets • Mini-tablets • Capsules • Powders • Granules • Beads/pellets • Non-sterile liquids • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug manufacturing expertise Commercial Packaging Solutions: Our high and low throughput operations provide the flexibility and efficiency necessary to meet your ongoing and fluctuating demand. Our commercial facilities in Europe and the US, combined with our local expertise offers flexible, quality-led commercial pharmaceutical packaging solutions tailored to meet your specific needs. Our range of primary packaging solutions include: • Tablets • Mini-tablets • Capsules • Powders • Granules • Non-sterile liquid • Our secondary packaging, labelling and assembly capabilities include: • Bottles Vials / ampoules • Pre-filled syringes • Wallets / blister cards • Auto-injectors • Cartons • Sachets • Stick packs • Offline blister printing Innovative, specialist packaging solutions including: • Specialist paediatric drug packaging expertise • Expert cell and gene therapy (ATMP) Ultra Low Temperature (ULT) solutions (-20° to -80°) • Complex medical kit assembly solutions via our unique, custom built semi-automated packaging technology Support Solutions: We provide a wide range of tailored support and consultancy services to help guide you through every aspect of your unique development and commercialisation journey. Find out more – www.almacgroup.com
Allucent
Allucent has 30+ years of global experience offering comprehensive drug development solutions focused on small to mid-size biopharma, specializing in the design and execution of oncology and hematology clinical trials. Our expertise spans all development phases, from preclinical through Phase IV, with deep experience in solid tumors and hematologic malignancies and across advanced therapeutic modalities including radiopharmaceuticals, CAR T, and ADCs. Our integrated solutions include regulatory consulting, clinical pharmacology, modeling & simulation, biostatistics, and clinical operations. | Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients. | Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients. Allucent nurtures a high-performance culture in which we provide continuous training, and put emphasis on personal and organizational development and opportunities, anchored by a commitment to high-quality and personalized customer service. We consider effective, frequent, and open communication a key component of developing strategies to meet your needs and goals. We provide lean project management to accomplish operational excellence in terms of timelines, quality, and costs.
Aliri Bioanalysis
Aliri Bioanalysis is a leading provider of advanced bioanalytical and spatial biomarker solutions for drug developers, with over 30 years of experience advancing life-saving molecules from non-clinical to clinical with speed and agility.
Advanced Science Laboratories Inc.
Advanced Science Laboratories, Inc. is an FDA registered, ISO 9001:2015 certified and GCP Compliant clinical testing and claim support laboratory head-quartered 35 miles outside midtown Manhattan. We provide a fully customizable scope of study protocols to address any of your unique claims. We utilize standard industry procedures specifically targeting cosmetic safety, hypoallergenic product claims and efficacy. Founded in 2020, we have recruited the finest minds to create the next generation of clinical testing. Experts ranging from board certified medical doctors to industry professionals with extensive experience in the fields of health and beauty aids (HBA), personal care and over-the-counter drugs have come together to forge this truly “advanced” service. We specialize in protocol development, safety and efficacy testing plus unique visual demonstrations of product efficacy. We conduct testing of sunscreens, antiperspirants, moisturizers, wrinkle treatments, hair products, and a wide range of topical applications. ADVANCED provides claim substantiation used by major corporations and television networks with the use of photographic, instrumental and biophysical measurements. All testing is conducted in-house in our newly renovated facility. We develop next generation strategies as well as new technologies incorporating scientific imaging to provide our clients with fully controlled, statistically valid studies. ADVANCED firmly believes that our unique process gives clients a superior edge, assuring their success in a very competitive marketplace. All global SPF and Ultraviolet-A Protection Factor (UVA-PF) testing methods for labeling requirements are also available. If possible, we invite all clients, contractors and consultants to visit our facility to become accustomed to our services and business model. We hope you will take us up on our offer. | Advanced Science Laboratories, Inc. is an FDA-registered, ISO 9001:2015-certified, and GCP-compliant clinical testing and claim support laboratory. We design fully customizable study protocols to substantiate your unique product claims, using industry-standard procedures for cosmetic safety, hypoallergenic testing, and efficacy evaluation. Established in 2020, ADVANCED unites a distinguished team of Board-Certified Medical Doctors and industry professionals with deep experience in beauty aids, personal care, and over-the-counter drugs. Our mission is to pioneer next-generation clinical testing services through innovative protocol development, rigorous safety and efficacy testing, and compelling visual demonstrations of product performance. We test a diverse range of products, including sunscreens, antiperspirants, moisturizers, wrinkle treatments, hair care, and topical formulations. Trusted by major corporations and television networks, ADVANCED delivers robust claim substantiation supported by photographic, instrumental, and biophysical data. All testing is conducted in-house at our state-of-the-art, newly renovated facility located in New York. Our cutting-edge strategies incorporate Matched Scientific PhotographyTM (MSPTM), ensuring statistically valid, fully controlled studies that give clients a competitive advantage in a dynamic marketplace. We provide comprehensive global SPF and Ultraviolet-A Protection Factor (UVA-PF) testing to meet labeling requirements. Pioneering “Beyond UV Testing,” ADVANCED offers exclusive methodologies for Blue Light (High Energy Visible; HEV), Visible, and Infrared Light. Our high-resolution Matched Scientific PhotographyTM, combined with standardized PhotoGrammetrix(R) (PhGx(R)) measurements, produces exquisitely detailed before-and-after images. These scientifically controlled visuals, accepted by international legal and regulatory bodies, quantify biophysical changes using advanced imaging systems. This powerful combination supports claim substantiation, marketing, and visual documentation, delivering unmatched value to our clients.
Admera Health
Admera Health is a trusted partner in advanced genomic and bioinformatic services to empower researchers with data-driven insights. Operating in a CLIA/CLEP-certified and CAP-accredited environment using state-of-the-art NGS technology, we offer a comprehensive suite of cutting-edge solutions to deliver high-resolution insights for oncology and drug discovery. From high-throughput gene expression screening and CRISPR sequencing to multi-omic spatial mapping, our expert team equipping scientists to identify biomarkers and accelerate therapeutics with unparalleled data quality and speed.